- Home
- STEL vs SDGR Comparison
STEL vs SDGR Comparison
Compare STEL & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEL
- SDGR
- Stock Information
- Founded
- STEL 2007
- SDGR 1990
- Country
- STEL United States
- SDGR United States
- Employees
- STEL N/A
- SDGR N/A
- Industry
- STEL Major Banks
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- STEL Finance
- SDGR Health Care
- Exchange
- STEL Nasdaq
- SDGR Nasdaq
- Market Cap
- STEL 1.5B
- SDGR 1.8B
- IPO Year
- STEL N/A
- SDGR 2020
- Fundamental
- Price
- STEL $27.78
- SDGR $19.74
- Analyst Decision
- STEL Hold
- SDGR Buy
- Analyst Count
- STEL 3
- SDGR 7
- Target Price
- STEL $29.67
- SDGR $32.29
- AVG Volume (30 Days)
- STEL 241.4K
- SDGR 868.2K
- Earning Date
- STEL 04-25-2025
- SDGR 04-30-2025
- Dividend Yield
- STEL 2.02%
- SDGR N/A
- EPS Growth
- STEL N/A
- SDGR N/A
- EPS
- STEL 2.15
- SDGR N/A
- Revenue
- STEL $433,918,000.00
- SDGR $207,539,000.00
- Revenue This Year
- STEL $2.12
- SDGR $24.42
- Revenue Next Year
- STEL $4.61
- SDGR $19.02
- P/E Ratio
- STEL $12.90
- SDGR N/A
- Revenue Growth
- STEL N/A
- SDGR N/A
- 52 Week Low
- STEL $21.27
- SDGR $16.67
- 52 Week High
- STEL $32.36
- SDGR $29.15
- Technical
- Relative Strength Index (RSI)
- STEL 48.61
- SDGR 38.14
- Support Level
- STEL $27.01
- SDGR $21.34
- Resistance Level
- STEL $28.15
- SDGR $22.85
- Average True Range (ATR)
- STEL 0.56
- SDGR 1.03
- MACD
- STEL 0.08
- SDGR -0.24
- Stochastic Oscillator
- STEL 71.01
- SDGR 15.96
About STEL Stellar Bancorp Inc.
Stellar Bancorp Inc is a U.S. based bank holding company. It mainly focuses on providing commercial banking solutions to local small and mid-sized businesses and professionals. The services provided by the company include business and personal deposits account, personal and business lending, mobile and online banking, merchant banking, and others. The company more than 50 full service banking centers.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.